Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 11, 2013, Pages 1484-1493

  Zhang, Junfang ^a,b   Cao, Hailong ^c   Zhang, Bing ^a   Cao, Hanwei ^a   Xu, Xiuqin ^a   Ruan, Hang ^a   Yi, Tingting ^a   Tan, Li ^a   Qu, Rui ^c   Song, Gang ^a   Wang, Bangmao ^c   Hu, Tianhui ^a  

^a XIAMEN UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Berberine; Colon cancer; Familial adenomatous polyposis; Signal transduction; Wnt

Indexed keywords

MUS;

ANTINEOPLASTIC AGENT; APC PROTEIN; BERBERINE; BETA CATENIN; CATNB PROTEIN, MOUSE;

ADOLESCENT; ADULT; ANIMAL; ARTICLE; C57BL MOUSE; CELL PROLIFERATION; COLON CANCER; COLON POLYPOSIS; DRUG EFFECT; DRUG SCREENING; FAMILIAL COLON POLYPOSIS; FEMALE; HUMAN; MALE; METABOLISM; MOUSE; PATHOLOGY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUMOR CELL LINE; UPREGULATION; WNT; WNT SIGNALING PATHWAY; YOUNG ADULT;

BERBERINE; COLON CANCER; FAMILIAL ADENOMATOUS POLYPOSIS; SIGNAL TRANSDUCTION; WNT;

ADENOMATOUS POLYPOSIS COLI; ADENOMATOUS POLYPOSIS COLI PROTEIN; ADOLESCENT; ADULT; ANIMALS; ANTICARCINOGENIC AGENTS; BERBERINE; BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTEIN TRANSPORT; UP-REGULATION; WNT SIGNALING PATHWAY; YOUNG ADULT;

EID: 84891147610     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12119     Document Type: Article

References (45)

1. Behrens J. The role of the Wnt signalling pathway in colorectal tumorigenesis. Biochem Soc Trans. 2005; 33: 672-5.
2. Waaler J, Machon O, von Kries JP, et al. Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth. Cancer Res. 2011; 71: 197-205.
3. Matushansky I, Maki RG, Cordon-Cardo C. A context dependent role for Wnt signaling in tumorigenesis and stem cells. Cell Cycle. 2008; 7: 720-4.
4. Sansom OJ, Meniel VS, Muncan V, et al. Myc deletion rescues Apc deficiency in the small intestine. Nature. 2007; 446: 676-9.
5. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol. 2006; 101: 385-98.
6. Caldwell GM, Jones CE, Soon Y, et al. Reorganisation of Wnt-response pathways in colorectal tumorigenesis. Br J Cancer. 2008; 98: 1437-42.
7. Tejpar S, Michils G, Denys H, et al. Analysis of Wnt/Beta catenin signalling in desmoid tumors. Acta Gastroenterol Belg. 2005; 68: 5-9.
8. Hino S, Tanji C, Nakayama KI, et al. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination. Mol Cell Biol. 2005; 25: 9063-72.
9. Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004; 10: 1344-51.
10. He BC, Gao JL, Zhang BQ, et al. Tetrandrine inhibits Wnt/{beta}-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol Pharmacol. 2011; 79: 211-9.
11. Zhang X, Gu L, Li J, et al. Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells. Cancer Res. 2010; 70: 9895-904.
12. Pandey MK, Sung B, Kunnumakkara AB, et al. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res. 2008; 68: 5370-9.
13. Singh T, Vaid M, Katiyar N, et al. Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E2 and prostaglandin E2 receptors. Carcinogenesis. 2011; 32: 86-92.
14. Domitrovic R, Jakovac H, Blagojevic G. Hepatoprotective activity of berberine is mediated by inhibition of TNF-alpha, COX-2, and iNOS expression in CCl(4)-intoxicated mice. Toxicology. 2011; 280: 33-43.
15. Hu Z, Jiao Q, Ding J, et al. Berberine induces dendritic cell apoptosis and has therapeutic potential for rheumatoid arthritis. Arthritis Rheum. 2011; 63: 949-59.
16. Saha P, Sen R, Hariharan C, et al. Berberine chloride causes a caspase-independent, apoptotic-like death in Leishmania donovani promastigotes. Free Radic Res. 2009; 43: 1101-10.
17. He BC, Gao JL, Zhang BQ, et al. Tetrandrine inhibits Wnt/{beta}-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol Pharmacol. 2011; 79: 211-9.
18. Salehi S, Filtz TM. Berberine possesses muscarinic agonist-like properties in cultured rodent cardiomyocytes. Pharmacol Res. 2011; 63: 335-40.
19. Zhou L, Wang X, Yang Y, et al. Berberine attenuates cAMP-induced lipolysis via reducing the inhibition of phosphodiesterase in 3T3-L1 adipocytes. Biochim Biophys Acta. 2011; 1812: 527-35.
20. Affuso F, Mercurio V, Fazio V, et al. Cardiovascular and metabolic effects of Berberine. World J Cardiol. 2010; 2: 71-7.
21. Boberek JM, Stach J, Good L. Genetic evidence for inhibition of bacterial division protein FtsZ by berberine. PLoS ONE. 2010; 5: e13745.
22. Liu W, Zhang X, Liu P, et al. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury. Eur J Pharmacol. 2010; 638: 150-5.
23. Hsu WH, Hsieh YS, Kuo HC, et al. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL. Arch Toxicol. 2007; 81: 719-28.
24. Thirupurasundari CJ, Padmini R, Devaraj SN. Effect of berberine on the antioxidant status, ultrastructural modifications and protein bound carbohydrates in azoxymethane-induced colon cancer in rats. Chem Biol Interact. 2009; 177: 190-5.
25. Tai WP, Luo HS. The inhibit effect of berberine on human colon cell line cyclooxygenase-2. Zhonghua Nei Ke Za Zhi. 2003; 42: 558-60.
26. Iizuka N, Hazama S, Yoshimura K, et al. Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma. Int J Cancer. 2002; 99: 286-91.
27. Fukuda K, Hibiya Y, Mutoh M, et al. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol. 1999; 66: 227-33.
28. Federico A, Morgillo F, Tuccillo C, et al. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer. 2007; 121: 2381-6.
29. Balkwill F, Mantovani A. Cancer and inflammation: implications for pharmacology and therapeutics. Clin Pharmacol Ther. 2010; 87: 401-6.
30. De Sousa EMF, Vermeulen L, Richel DJ, et al. Targeting Wnt signaling in colon cancer stem cells. Clin Cancer Res. 2011; 17: 647-53.
31. Rask K, Nilsson A, Brannstrom M, et al. Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta. Br J Cancer. 2003; 89: 1298-304.
32. Harrison C. G protein-coupled receptors: insights into chemokine receptors. Nat Rev Drug Discov. 2010; 9: 920.
33. Lefkowitz RJ. G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J Biol Chem. 1998; 273: 18677-80.
34. Bhadra K, Maiti M, Kumar GS. Berberine-DNA complexation: new insights into the cooperative binding and energetic aspects. Biochim Biophys Acta. 2008; 1780: 1054-61.
35. Corpet DE, Pierre F. How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men. Eur J Cancer. 2005; 41: 1911-22.
36. Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol. 1999; 19: 1-11.
37. Rosin-Arbesfeld R, Cliffe A, Brabletz T, et al. Nuclear export of the APC tumour suppressor controls beta-catenin function in transcription. EMBO J. 2003; 22: 1101-13.
38. Wu K, Yang Q, Mu Y, et al. Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/beta-catenin signaling. Int J Oncol. 2012; 41: 292-8.
39. Wang Y, Kheir MM, Chai Y, et al. Comprehensive study in the inhibitory effect of berberine on gene transcription, including TATA box. PLoS ONE. 2011; 6: e23495.
40. Kulkarni SK, Dhir A. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. Eur J Pharmacol. 2007; 569: 77-83.
41. Khor TO, Gul YA, Ithnin H, et al. A comparative study of the expression of Wnt-1, WISP-1, survivin and cyclin-D1 in colorectal carcinoma. Int J Colorectal Dis. 2006; 21: 291-300.
42. He B, Reguart N, You L, et al. Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. Oncogene. 2005; 24: 3054-8.
43. You Z, Saims D, Chen S, et al. Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol. 2002; 157: 429-40.
44. Gandhirajan RK, Staib PA, Minke K, et al. Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo. Neoplasia. 2010; 12: 326-35.
45. Deng L, Hu S, Baydoun AR, et al. Aspirin induces apoptosis in mesenchymal stem cells requiring Wnt/beta-catenin pathway. Cell Prolif. 2009; 42: 721-30.